About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
The Truth About Current Consensus Statements on Hematopoietic Cell Transplant
By
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
FEATURING
Robert Peter Gale
By
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
FEATURING
Robert Peter Gale
454 views
February 15, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
16:26
Incyte
Effects of a Treatment Option on Hematocrit Control and Spleen Volum…
Feat.
C. Harrison
Featured Video
37:21
Amgen Sponsorship
New Approval for Frontline Consolidation in Patients with CD19-posit…
Feat.
J. Mccloskey
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
16:57
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Lymphoma Highlights"
Feat.
B. D. Cheson
22:37
Insights from 2023 ASH Annual Meeting
AML and MDS Highlights & Key Takeaways
Feat.
T. Badar
27:49
Insights from 2024 EHA Annual Meeting
AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024
Feat.
T. Badar
22:11
SOHO Brazil 2024
Has the 1L SoC Truly Changed in Advanced Stage DLBCL?
Feat.
A. Zelenetz
17:51
Indy Hematology Review
Treatment of AML: Managing the Patient When Transplant Is Not an Opt…
Feat.
H. Erba
13:07
Moffitt Cancer Center
R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?
Feat.
J. Chavez
31:53
Indy Hematology Review
HSCT in 2024: What Every Hematologist Needs to Know
Feat.
R. Childs
27:47
Indy Hematology Review
Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…
Feat.
S. Smith
19:21
SOHO Brazil 2024
Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde
Feat.
J. Lancet
27:26
SOHO Brazil 2024
Where I Use Azacitidine and Venetoclax in AML: Present and Future
Feat.
J. Lancet
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
28:02
University of Colorado Division of Hematology
2024 Updates in AML
Feat.
C. McMahon
22:30
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Emerging Treatment Options for AML in 2024
Feat.
A. Perl
08:47
Sarah Tasian
Recent Updates on Blinatumomab in ALL: FDA Approval in 1L and Incorp…
35:27
Louisville Hematology Highlights
Updates on Management of DLBCL
Feat.
J. Leonard
10:04
Tara Graff
How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…
09:18
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…
Feat.
J. Westin
14:32
Vanderbilt University Medical Center (VUMC)
Summary of Recent Updates in MDS
Feat.
S. Ball
